Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer D Wu

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Opinion in Immunology|March 12, 2018
NKG2D and its ligands in cancerPayal Dhar, Jennifer D Wu
Journal of Clinical Medicine|September 25, 2019
NK Cell Plasticity in CancerSizhe Liu, Payal Dhar, Jennifer D Wu
Frontiers in Immunology|March 20, 2015
NKG2D Ligands in Tumor Immunity: Two Sides of a CoinJinyu Zhang, Fahmin Basher, Jennifer D Wu
Journal of Health Economics|April 5, 2024
Politics and health care spending in the United States: A case study from the passage of the 2003 Medicare Modernization ActZack Cooper, Amanda Kowalski, Eleanor Neff Powell, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinasesGang Liu, Catherine L Atteridge, Xuanjun Wang, et al.
Journal of Hematology & Oncology|April 19, 2015
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotypeGang Xiao, Xuanjun Wang, Jun Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formationJennifer D Wu, Catherine L Atteridge, Xuanjun Wang, et al.
Journal of Cellular Biochemistry|April 28, 2006
Interaction of IGF signaling and the androgen receptor in prostate cancer progressionJennifer D Wu, Kathy Haugk, Libby Woodke, et al.
Journal for Immunotherapy of Cancer|August 27, 2019
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC<sup>+</sup> tumors respond to PD1/PD-L1 blockade therapyJinyu Zhang, Pablo Saenz-Lopez Larrocha, Bin Zhang, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Opinion in Immunology|March 12, 2018
NKG2D and its ligands in cancerPayal Dhar, Jennifer D Wu
Journal of Clinical Medicine|September 25, 2019
NK Cell Plasticity in CancerSizhe Liu, Payal Dhar, Jennifer D Wu
Frontiers in Immunology|March 20, 2015
NKG2D Ligands in Tumor Immunity: Two Sides of a CoinJinyu Zhang, Fahmin Basher, Jennifer D Wu
Journal of Health Economics|April 5, 2024
Politics and health care spending in the United States: A case study from the passage of the 2003 Medicare Modernization ActZack Cooper, Amanda Kowalski, Eleanor Neff Powell, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinasesGang Liu, Catherine L Atteridge, Xuanjun Wang, et al.
Journal of Hematology & Oncology|April 19, 2015
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotypeGang Xiao, Xuanjun Wang, Jun Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formationJennifer D Wu, Catherine L Atteridge, Xuanjun Wang, et al.
Journal of Cellular Biochemistry|April 28, 2006
Interaction of IGF signaling and the androgen receptor in prostate cancer progressionJennifer D Wu, Kathy Haugk, Libby Woodke, et al.
Journal for Immunotherapy of Cancer|August 27, 2019
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC<sup>+</sup> tumors respond to PD1/PD-L1 blockade therapyJinyu Zhang, Pablo Saenz-Lopez Larrocha, Bin Zhang, et al.
Pageof 5